Nothing Special   »   [go: up one dir, main page]

Park et al., 2019 - Google Patents

Comparing the membrane-interaction profiles of two antiviral peptides: Insights into structure–function relationship

Park et al., 2019

Document ID
16763335105732079722
Author
Park S
Jackman J
Cho N
Publication year
Publication venue
Langmuir

External Links

Snippet

In recent years, certain amphipathic, α-helical peptides have been discovered that inhibit medically important enveloped viruses by disrupting the lipid membrane surrounding individual virus particles. Interestingly, only a small subset of amphipathic, α-helical peptides …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Similar Documents

Publication Publication Date Title
Park et al. Comparing the membrane-interaction profiles of two antiviral peptides: Insights into structure–function relationship
Guha et al. Mechanistic landscape of membrane-permeabilizing peptides
Dehsorkhi et al. Interaction between a cationic surfactant-like peptide and lipid vesicles and its relationship to antimicrobial activity
Thorén et al. Membrane binding and translocation of cell-penetrating peptides
Jones et al. Length-dependent formation of transmembrane pores by 310-helical α-aminoisobutyric acid foldamers
Andreev et al. Cyclization improves membrane permeation by antimicrobial peptoids
Karim et al. Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase
Papo et al. Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides
Edwards-Gayle et al. Self-assembly, antimicrobial activity, and membrane interactions of arginine-capped peptide bola-amphiphiles
Ghosh et al. Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP
Zhong et al. New antimicrobial peptides with repeating unit against multidrug-resistant bacteria
Raghava et al. SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release
Jackman et al. Deciphering how pore formation causes strain-induced membrane lysis of lipid vesicles
Beter et al. Multivalent presentation of cationic peptides on supramolecular nanofibers for antimicrobial activity
Pattnaik et al. Enhanced cholesterol-dependent hemifusion by internal fusion peptide 1 of SARS coronavirus-2 compared to its N-terminal counterpart
Ghosh et al. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus
Macháň et al. Peripheral and integral membrane binding of peptides characterized by time-dependent fluorescence shifts: focus on antimicrobial peptide LAH4
dos Santos Cabrera et al. Combining experimental evidence and molecular dynamic simulations to understand the mechanism of action of the antimicrobial octapeptide jelleine-I
Hammond et al. Switching cytolytic nanopores into antimicrobial fractal ruptures by a single side chain mutation
Stulz et al. Quantified membrane permeabilization indicates the lipid selectivity of membrane-active antimicrobials
Galdiero et al. The presence of a single N-terminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H
Guo et al. Feleucin-K3 analogue with an α-(4-Pentenyl)-Ala substitution at the key site has more potent antimicrobial and antibiofilm activities in vitro and in vivo
He et al. Uncoupling amphipathicity and hydrophobicity: Role of charge clustering in membrane interactions of cationic antimicrobial peptides
Tate et al. Peptidomimetic oligomers targeting membrane phosphatidylserine exhibit broad antiviral activity
Al Nahas et al. Measuring thousands of single-vesicle leakage events reveals the mode of action of antimicrobial peptides